Perspective Therapeutics (CATX) Raw Materials (2011 - 2023)
Perspective Therapeutics (CATX) posted Raw Materials of $764000.0 for Q3 2023, down 2.18% sequentially from $781000.0 in Q2 2023, and down 16.23% YoY from $912000.0 in Q3 2022.
Perspective Therapeutics (CATX) Raw Materials (2011 - 2023) Analysis & Trends
Perspective Therapeutics has reported Raw Materials for 11 years, with the latest figure at $764000.0 in Q3 2023.
- Quarterly Raw Materials fell 16.23% year-over-year to $764000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $764000.0 (down 16.23% YoY) and the FY2022 annual result came in at $752000.0, changed N/A from the prior year.
- Raw Materials retreated to $764000.0 in Q3 2023 per CATX's latest filing, from $781000.0 in the prior quarter.
- Over five years, Raw Materials peaked at $912000.0 in Q3 2022 and troughed at $330000.0 in Q3 2019.
- A 5-year average of $598105.3 and a median of $645000.0 in 2021 frame the typical range for Raw Materials.
- The sharpest annual moves came in 2021 and 2023: Raw Materials soared 98.69% in 2021, then declined 16.23% in 2023.
- Over 5 years, Raw Materials stood at $372000.0 in 2019, then grew by 20.43% to $448000.0 in 2020, then soared by 67.63% to $751000.0 in 2021, then rose by 0.13% to $752000.0 in 2022, then rose by 1.6% to $764000.0 in 2023.
- According to Business Quant data, Raw Materials over the past three periods registered $764000.0, $781000.0, and $777000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Perspective Therapeutics | 388.50 Mn | 388.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 764,000.00 |
| Jun 30, 2023 | 781,000.00 |
| Mar 31, 2023 | 777,000.00 |
| Dec 31, 2022 | 752,000.00 |
| Sep 30, 2022 | 912,000.00 |
| Jun 30, 2022 | 911,000.00 |
| Mar 31, 2022 | 789,000.00 |
| Dec 31, 2021 | 751,000.00 |
| Sep 30, 2021 | 757,000.00 |
| Jun 30, 2021 | 645,000.00 |
| Mar 31, 2021 | 508,000.00 |
| Dec 31, 2020 | 448,000.00 |
| Sep 30, 2020 | 381,000.00 |
| Jun 30, 2020 | 401,000.00 |
| Mar 31, 2020 | 369,000.00 |
| Dec 31, 2019 | 372,000.00 |
| Sep 30, 2019 | 330,000.00 |
| Jun 30, 2019 | 333,000.00 |
| Mar 31, 2019 | 383,000.00 |
| Dec 31, 2018 | 379,000.00 |